Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Translational Oncology
|
December 12, 2018
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine
Hayley Leeman, Elwira Kaminska, Deborah Green, et al.
Tumori
|
March 15, 2005
Treatment options in hormone-refractory metastatic prostate carcinoma
Alberto Fusi, Giuseppe Procopio, Silvia Della Torre, et al.
American Journal of Clinical Oncology
|
December 15, 2004
Epirubicin, cisplatin, and raltitrexed in patients with advanced gastric and hepatobiliary carcinoma: a phase II study
Vittorio D Ferrari, Vito Amoroso, Francesca Valcamonico, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2011
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma
Antonia Busse, Anne Marie Asemissen, Anika Nonnenmacher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 2, 2008
Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?
Diego Cortinovis, Paolo Bidoli, Daniela Cullurà, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 2, 2009
Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study)
Alberto Fusi, Sandra Collette, Antonia Busse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2013
Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer
Radosław Polański, Cassandra L Hodgkinson, Alberto Fusi, et al.
Cancer Immunology, Immunotherapy : CII
|
April 30, 2013
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)
Antonia Busse, Jérôme Rapion, Alberto Fusi, et al.
Cancer Discovery
|
December 31, 2015
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma
Maria Romina Girotti, Gabriela Gremel, Rebecca Lee, et al.
Cancer Discovery
|
February 6, 2026
Expression of Concern: Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma
Maria R Girotti, Gabriela Gremel, Rebecca Lee, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Translational Oncology
|
December 12, 2018
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine
Hayley Leeman, Elwira Kaminska, Deborah Green, et al.
Tumori
|
March 15, 2005
Treatment options in hormone-refractory metastatic prostate carcinoma
Alberto Fusi, Giuseppe Procopio, Silvia Della Torre, et al.
American Journal of Clinical Oncology
|
December 15, 2004
Epirubicin, cisplatin, and raltitrexed in patients with advanced gastric and hepatobiliary carcinoma: a phase II study
Vittorio D Ferrari, Vito Amoroso, Francesca Valcamonico, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2011
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma
Antonia Busse, Anne Marie Asemissen, Anika Nonnenmacher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 2, 2008
Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?
Diego Cortinovis, Paolo Bidoli, Daniela Cullurà, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 2, 2009
Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study)
Alberto Fusi, Sandra Collette, Antonia Busse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2013
Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer
Radosław Polański, Cassandra L Hodgkinson, Alberto Fusi, et al.
Cancer Immunology, Immunotherapy : CII
|
April 30, 2013
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)
Antonia Busse, Jérôme Rapion, Alberto Fusi, et al.
Cancer Discovery
|
December 31, 2015
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma
Maria Romina Girotti, Gabriela Gremel, Rebecca Lee, et al.
Cancer Discovery
|
February 6, 2026
Expression of Concern: Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma
Maria R Girotti, Gabriela Gremel, Rebecca Lee, et al.
Page
of 5